$115 Billion is the total value of PRIMECAP MANAGEMENT CO/CA/'s 331 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Exit | TUESDAY MORNING CORP | $0 | – | -29,666 | -100.0% | 0.00% | – | |
| AVO | Exit | MISSION PRODUCE INC | $0 | – | -43,280 | -100.0% | 0.00% | – |
| SIOX | Exit | SIO GENE THERAPIES INC | $0 | – | -12,000 | -100.0% | 0.00% | – |
| Exit | CALITHERA BIOSCIENCES INC | $0 | – | -401,080 | -100.0% | -0.00% | – | |
| MSGS | Exit | MADISON SQUARE GRDN SPRT CORcl a | $0 | – | -6,773 | -100.0% | -0.00% | – |
| MTLS | Exit | MATERIALISE NVsponsored ads | $0 | – | -155,000 | -100.0% | -0.00% | – |
| KR | Exit | KROGER CO | $0 | – | -25,000 | -100.0% | -0.00% | – |
| FWONA | Exit | LIBERTY MEDIA CORP DEL | $0 | – | -22,400 | -100.0% | -0.00% | – |
| SAFE | Exit | SAFEHOLD INC | $0 | – | -53,600 | -100.0% | -0.00% | – |
| NOK | Exit | NOKIA CORPsponsored adr | $0 | – | -500,000 | -100.0% | -0.00% | – |
| PBH | Exit | PRESTIGE CONSMR HEALTHCARE I | $0 | – | -31,400 | -100.0% | -0.00% | – |
| MSGE | Exit | MADISON SQUARE GRDN ENTERTNMcl a | $0 | – | -642,751 | -100.0% | -0.03% | – |
| LIN | Exit | LINDE PLC | $0 | – | -280,000 | -100.0% | -0.08% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LILLY ELI & CO | 42 | Q3 2023 | 10.5% |
| BIOGEN INC. | 42 | Q3 2023 | 6.8% |
| AMGEN INC. | 42 | Q3 2023 | 5.3% |
| MICROSOFT CORP. | 42 | Q3 2023 | 4.2% |
| ADOBE SYSTEMS INCORPORATED | 42 | Q3 2023 | 4.1% |
| TEXAS INSTRS. INC. | 42 | Q3 2023 | 3.5% |
| FEDEX CORP | 42 | Q3 2023 | 3.3% |
| SOUTHWEST AIRLS CO | 42 | Q3 2023 | 3.8% |
| NOVARTIS AG ADR | 42 | Q3 2023 | 2.7% |
| MICRON TECHNOLOGY INC | 42 | Q3 2023 | 2.8% |
View PRIMECAP MANAGEMENT CO/CA/'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NEKTAR THERAPEUTICS | July 07, 2023 | 8,149,876 | 4.3% |
| STANDARD BIOTOOLS INC. | July 07, 2023 | 3,220,917 | 4.1% |
| Calithera Biosciences, Inc. | February 09, 2023 | 401,080 | 8.2% |
| CERUS CORP | January 09, 2023 | 8,849,600 | 5.0% |
| COMSCORE, INC. | January 09, 2023 | 2,883,435 | 3.1% |
| STRATASYS LTD. | December 08, 2022 | 3,176,499 | 4.8% |
| Wave Life Sciences Ltd. | December 08, 2022 | 4,225,908 | 4.9% |
| NN INC | November 09, 2022 | 1,763,640 | 4.0% |
| AXCELIS TECHNOLOGIES INC | October 07, 2022 | 1,649,466 | 5.0% |
| Epizyme, Inc.Sold out | September 08, 2022 | 0 | 0.0% |
View PRIMECAP MANAGEMENT CO/CA/'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
View PRIMECAP MANAGEMENT CO/CA/'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.